<SEC-DOCUMENT>0000947871-24-001051.txt : 20241230
<SEC-HEADER>0000947871-24-001051.hdr.sgml : 20241230
<ACCEPTANCE-DATETIME>20241230062022
ACCESSION NUMBER:		0000947871-24-001051
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20241230
DATE AS OF CHANGE:		20241230

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AEye, Inc.
		CENTRAL INDEX KEY:			0001818644
		STANDARD INDUSTRIAL CLASSIFICATION:	MOTOR VEHICLE PARTS & ACCESSORIES [3714]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				371827430
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-274546
		FILM NUMBER:		241586907

	BUSINESS ADDRESS:	
		STREET 1:		4670 WILLOW ROAD, SUITE 125
		CITY:			PLEASANTON
		STATE:			CA
		ZIP:			94588
		BUSINESS PHONE:		925-400-4366

	MAIL ADDRESS:	
		STREET 1:		4670 WILLOW ROAD, SUITE 125
		CITY:			PLEASANTON
		STATE:			CA
		ZIP:			94588

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CF Finance Acquisition Corp. III
		DATE OF NAME CHANGE:	20200717
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>ss4283464_424b5.htm
<DESCRIPTION>PROSPECTUS SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Filed Pursuant to Rule 424(b)(5)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Registration No. 333-274546</B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>PROSPECTUS SUPPLEMENT</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>(To Prospectus Supplement dated September 13, 2024 to Prospectus dated
September 15, 2023)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><FONT STYLE="font-size: 12pt"><B><IMG SRC="image_001.jpg" ALT="" STYLE="height: 92px; width: 336px"></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B>AEYE, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B>Up to $5,230,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B>Common Stock<FONT STYLE="font-size: 12pt"><BR>
</FONT>______________</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">This Prospectus Supplement amends and supplements
the information in the prospectus, dated September 15, 2023 (the &ldquo;Prospectus&rdquo;), filed with the Securities and Exchange Commission
as a part of our registration statement on Form S-3 (File No. 333-274546), as previously supplemented by our prospectus supplement, dated
September 13, 2024 (the &ldquo;Prior Supplement&rdquo; and together with the Prospectus, the &ldquo;Prior Prospectus&rdquo;), relating
to the offer and sale of shares of our common stock having an aggregate offering price of up to $2,600,000 pursuant to the terms of At
Market Issuance Sales Agreement, dated September 12, 2024 (the &ldquo;Sales Agreement&rdquo;), with A.G.P./Alliance Global Partners (&ldquo;A.G.P.&rdquo;).
This Prospectus Supplement should be read in conjunction with the Prior Prospectus, and is qualified by reference thereto, except to the
extent that the information herein amends or supersedes the information contained in the Prior Prospectus. This Prospectus Supplement
is not complete without, and may only be delivered or utilized in connection with, the Prior Prospectus and any future amendments or supplements
thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We are filing this Prospectus Supplement to
amend the Prior Prospectus to update the maximum amount of shares that we are eligible to sell under our Registration Statement pursuant
to the Sales Agreement under General Instruction I.B.6 of Form S-3. As a result of these limitations and the current public float of our
common stock, and in accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock having an aggregate
offering price of up to $5,230,000 from time to time through A.G.P. In the event that we may sell additional amounts under the Sales Agreement
in accordance with General Instruction I.B.6, we will file another prospectus supplement prior to making such additional sales. This Prospectus
Supplement amends and/or supplements only those sections of the Prior Prospectus as listed in this Prospectus Supplement, and all other
sections of the Prior Prospectus remain as is.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">We are an &ldquo;emerging growth company&rdquo;
and &ldquo;smaller reporting company&rdquo; as defined under U.S. federal securities laws and are subject to reduced public company reporting
requirements. Our common stock is listed on the Nasdaq Capital Market (&ldquo;Nasdaq&rdquo;) under the symbol &ldquo;LIDR.&rdquo; The
last sale price of our common stock, as reported on Nasdaq on December 27, 2024, was $2.04  per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in">As of December 27, 2024, the aggregate
market value of our outstanding shares of common stock held by non-affiliates, or public float, was determined to be $23,235,139
based on 12,005,988 shares of common stock outstanding, of which 616,214  are held by non-affiliates, and at a price of
$2.04 per share, the closing price of our common stock on December 27, 2024. In no event will the aggregate market value of
securities sold by us or on our behalf pursuant to General Instruction I.B.6 of Form S-3 during the 12 calendar month period
immediately prior to, and including, the date of any such sale exceed one-third of the aggregate market value of our shares of
common stock held by non-affiliates, so long as the aggregate market value of our common stock held by non-affiliates is less than
$75,000,000. During the prior 12 calendar month period that ends on, and includes, December 27, 2024, we have
sold $5,105,173 of our securities pursuant to General Instruction I.B.6 of Form S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center">______________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.5in"><B>Investing in our
common stock involves a high degree of risk. See the &ldquo;Risk Factors&rdquo; section beginning on page S-6 of the Prior
Supplement and the documents incorporated by reference into this Prospectus Supplement and the Prior Prospectus, as they may be
amended, updated or supplemented periodically in our reports filed with the Securities and Exchange Commission, before investing in our common stock</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities or determined if this Prospectus Supplement or the
Prior Prospectus are truthful or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.5in"></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B>A.G.P.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B>The date of this prospectus supplement is
December 30, 2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !S :0# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOR/5O^%VV7_0*F_[Z%=;X.\;6GB^*X,,302P$;HV.3@]Z^?/^$?UK_H$WO\
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MNW\"33RL?(5QD(H[X]37JJJ%4*H  X  Z5\NVGC#Q%8VL=M:ZO=0P1C"(C8
M%3?\)WXJ_P"@[>?]]U%7"5:DG)R*HXVE3@HJ+_ ^G:*^8O\ A._%7_0=O/\
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M7_?H_P"-'_"C[G_H-1?]^C_C7-[7"^7W'5[+&>?WG*_\+/\ %W_04'_?E?\
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M  I"P_Z#%U_W[6C_ (4A8?\ 08NO^_:UTG_"TO"G_/\ -_W[-'_"TO"G_/\
M-_W[-'M,5Y_<'L\'Y?>8=A\&K*QU&UO%U:Y9H)5E"E%P<'.*].KC1\4?"I(
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M]9@NL3SGEKZ2/E/<OJ/SHW+ZC\Z^J_\ A&]#_P"@/8?^ Z?X4?\ "-Z'_P!
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M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
# __9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
